Pharmaceutical Business Review
The authorisation applies to adults with resectable MIBC who cannot be treated with cisplatin-based chemotherapy.
Pharmaceutical Business Review
The authorisation applies to adults with resectable MIBC who cannot be treated with cisplatin-based chemotherapy.
Pharmaceutical Business Review
The authorisation applies to adults with resectable MIBC who cannot be treated with cisplatin-based chemotherapy.